BEHAVIOURAL SCIENCE IN CANCER SCREENING, CONTROL AND COMMUNICATION
With
Dr Rachael Dodd
Senior Research Fellow,
The Daffodil Centre, a Cancer Council NSW & The University of Sydney Joint Venture
Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney | April 2025
Dr Dodd completed her undergraduate in Psychology (2007), Masters in Health Psychology (2009) and PhD in Psychology (2016) in the UK. Her PhD focused on the psychosocial impact of HPV in people diagnosed with head and neck cancer, which resulted in the development of an education resource which is being implemented into clinical practice here in Australia and is available online. Dr Dodd relocated to The University of Sydney in Australia in 2017, following the completion of her PhD. Her research capitalised on her expertise in HPV and focused on the changes to the cervical screening program that commenced in Australia in 2017.
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
Dr Dodd has published 78 research papers and is a CI on grants worth over $20 million. This has included being the lead investigator of an International Lung Cancer Foundation Young Investigator Grant, to co-design decision support tools for lung cancer screening in Australia and she is leading a consortium to develop the suite of information materials and education resources for the upcoming National Lung Cancer Screening Program.
Source: Supplied
https://orcid.org/0000-0002-8080-6359
-
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.
-
Paramedics in the Community
Dr Brendan Shannon is a registered paramedic and Head of Postgraduate Programs and Deputy Head of Department of Paramedicine at Monash University.
Brendan has a keen research interest in alternative care pathways, non-transport, referral services, paramedic practitioners and community paramedicine. His Doctoral research focused on investigating the experiences of health services when implementing alternative care pathways.
-
Pathogenicity, modelling & treatment of inherited retinal Stargardt disease
Dr Di Huang is a Research Associate at the Lions Eye Institute (LEI), working with A/Professor Fred Chen and Dr Sam McLenachan. Her research focuses on developing a robust platform of retinal pigment epithelium cells and retinal organoids derived from patient-specific induced pluripotent stem cells to model inherited retinal diseases, particularly Stargardt disease (STGD1).
